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Abstract
Invariant natural killer T (iNKT) cells are innate-like T lymphocytes that act as critical regulators 
of the immune response. To better characterize this population, we profiled iNKT cell gene 
expression during ontogeny and in peripheral subsets as part of the Immunological Genome 
Project (ImmGen). High-resolution comparative transcriptional analyses defined developmental 
and subset-specific iNKT cell gene expression programs. In addition, iNKT cells were found to 
share an extensive transcriptional program with natural killer (NK) cells, similar in magnitude to 
that shared with major histocompatibility complex (MHC)-restricted T cells. Strikingly, the NK- 
iNKT program also operated constitutively in śŜT cells and in adaptive T cells following 
activation. Together, our findings highlight a core effector program regulated distinctly in innate 
and adaptive lymphocytes.
Introduction
The Immunological Genome Project (ImmGen) is a consortium of immunologists and 
computational biologists who aim, using rigorously standardized experimental and analysis 
pipelines, to generate a high-resolution, comprehensive definition of gene expression and 
regulatory networks in the mouse immune system1. In this context, we determined global 
gene expression profiles for thymic and peripheral invariant natural killer T (iNKT) cell 
subsets to gain insight into the iNKT cell transcriptional landscape, its unique features, and 
the relationships of iNKT cells to other innate and adaptive cell lineages.
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iNKT cells are a subset of řŚ T cells with an semi-invariant T cell antigen receptor (TCR) 
recognizing lipid antigens presented by CD1d2. By rapidly producing cytokines, these cells 
modulate both the innate and adaptive arms of the immune system, critically affecting 
biological processes in anti-microbial immunity, tumor rejection, and inflammation3. Like 
MHC-restricted T cells, iNKT cells undergo thymic differentiation with somatic 
recombination4, recognize self and foreign antigens2,3, secrete TH1, TH 2, and TH17 
cytokines5, and provide help to B cells6.
The term “ NK T”  was coined to reflect the expression of the natural killer (NK) cell marker 
NK1.17. While a number of other NK receptors (NKRs) can also be expressed by iNKT 
cells8, the validity of the term “ NKT”  has been called into question9 because iNKT cells are 
developmentally more closely related to the T than the NK cell lineage, and because NKRs 
are neither specific to iNKT cells nor expressed on all iNKT cells.
While a central role for TCR-mediated activation in iNKT cell biology is clear, striking 
parallels in the behavior of both NK and iNKT cells have nevertheless emerged. The 
homeostatic distribution and survival requirements of iNKT cells are similar to those of NK 
cells10,11,12,13. Also comparable are their trafficking and activation kinetics. Both cell types 
constitutively express inflammatory chemokine receptors, accumulate at sites of infection 
within 24–72 h, and exert their effector functions without a priming requirement14,15. In 
addition, evidence suggests that iNKT cells, like NK cells, can use activating NKRs to sense 
stress-induced ligands15–19. iNKT cells also detect cellular stress via their TCRs, which are 
reactive to inflammation-induced alterations in CD1d-presented self-lipid antigens20–22. 
Finally, NK and iNKT cells engage in comparable bidirectional interactions with antigen 
presenting cells (APCs) during which APC-derived inflammatory cytokines potentiate NK 
and iNKT responses to surface ligands, and NK or iNKT cells, in return, promote APC 
maturation23–28.
In this report, we shed light on the transcriptional programs operating over the course of 
iNKT cell development and in peripheral CD4+ and CD4− iNKT cell subsets. Utilizing the 
ImmGen compendium, which allows direct comparison of gene expression in developing 
and mature iNKT, NK, and T cell subsets, we assess the transcriptional basis for NK- iNKT 
similarities. Our data demonstrate that shared NK- iNKT transcriptional programs are more 
extensive than currently appreciated and comparable in breadth to those shared by iNKT and 
MHC-restricted T cells. Finally, we show that the transcriptional patterns expressed 
constitutively by both NK and iNKT cells represent a core effector program also operational 
in other innate lymphocytes and induced in adaptive lymphocyte populations following 
activation.
Results
iNKT cell-specific developmental programs
iNKT cells, like other T lymphocytes, mature in the thymus, where they diverge from MHC-
restricted řŚ T cells at the CD4+ CD8+ double-positive (DP) stage. iNKT cells subsequently 
undergo sequential stages of differentiation characterized by differential expression of CD44 
and NK1.14 (Supplementary Fig. 1). To characterize the developmental transcriptional 
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programs in iNKT cells in relation to those operating in maturing adaptive řŚ T cells, we 
profiled CD44− NK1.1− (stage 1), CD44+NK1.1− (stage 2) and CD44+NK1.1+ (stage 3) 
thymic iNKT cells in the context of the ImmGen Project (Fig. 1a). 1850, 155 and 697 genes 
were differentially expressed from DP to stage 1, stage 1 to stage 2, and stage 2 to stage 3, 
respectively, using an arbitrary fold change (FC) threshold of FC > 2 (Fig. 1b, c). 
Transcripts modulated between thymic iNKT cell populations included a number of genes 
involved in iNKT cell maturation4 as well as several genes of unknown function 
(Supplementary Tables 1–6). At the DP branch point, we identified a subset of genes 
modulated selectively by stage 1 iNKT cells but not by early stage CD4+ adaptive T cells 
(CD4+8int) (Fig. 1d). Although some of these genes such as Zbtb16 (PLZF) and Vdr 
(vitamin D receptor) are known to play important functions in iNKT cell lineage 
specification29–31, many have not yet been linked to iNKT cell development 
(Supplementary Tables 7, 8). At the last iNKT cell maturation stage, many of the most 
strongly upregulated genes belonged to the killer lectin receptor family, which encodes 
activating and inhibitory NK receptors (NKRs) (Fig. 1c, bottom panel). By the final stage of 
ontogeny, iNKT cells expressed several NKR mRNAs at levels comparable to those of 
splenic NK cells (Supplementary Fig. 2a). In addition, NKR upregulation occurs selectively 
in developing iNKT cells but not in maturing MHC-restricted T cells or at any stage in early 
T cell development, with a few exceptions (Fig. 1e). Flow cytometric analysis of thymic 
iNKT cells confirmed the acquisition of surface NKRs over the course of maturation (Fig. 1f 
and Supplementary Fig. 2b). K-means clustering analysis determined that a large number of 
genes follow the same expression kinetics as NKRs over the course of the DP to stage 3 
transition (Fig. 1g) suggesting that the progressive upregulation of NKRs may be part of a 
broader gene program. Together, these data comprehensively characterize shared and 
distinct gene expression changes occurring in maturing iNKT cells in the broader context of 
řŚ T cell development.
Peripheral iNKT cell transcriptional signatures
In both mouse and human, differential cytokine production has been reported between CD4+ 
and CD4− iNKT cells5,32,33. In addition, iNKT cell subsets from the liver have also been 
suggested to be functionally distinct34. To characterize the transcriptional basis that may 
underlie subset-specific functional differences, we assessed the gene expression profiles of 
CD4+ and CD4− iNKT cells sorted from the spleen, liver and lungs of mice. 159 and 261 
genes were differentially expressed between CD4+ and CD4− iNKT cells from the spleen or 
lung, respectively, while only 17 transcripts were differentially expressed between the liver 
subsets (Fig. 2a, Supplementary Fig. 3 and Supplementary Tables 9–14), suggesting that 
splenic and pulmonary iNKT cell subsets may be more functionally distinct from each other 
than are liver iNKT cell subsets. In all three tissues, we found that a number of NKRs were 
among the most differentially expressed genes, with elevated levels in CD4− compared to 
CD4+ subsets (Fig. 2a and Supplementary Fig. 3). In liver and spleen, this reflected a larger 
percentage of NKR-positive cells in CD4− compared to CD4+ iNKT cells, as determined by 
flow cytometry (Fig. 2b). NKR mRNA expression in peripheral iNKT cells, although 
reduced compared to stage 3 thymic iNKT cells, was maintained at higher levels than most 
MHC-restricted řŚ T cell subsets (Fig. 2c and data not shown). In addition, comparison of 
liver iNKT cell subsets to their splenic counterparts revealed that CD4− populations are 
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more transcriptionally similar to one another than are CD4+ iNKT cells across tissues. A 
small number of genes were expressed differentially between tissues regardless of CD4 
expression (Supplementary Fig. 4), supporting the idea that iNKT cells subsets may perform 
organ-specific functions.
An extensive NK- iNKT shared transcriptional program
Because iNKT cells share broad functional features with NK cells, we hypothesized that 
NKR expression by iNKT cells might reflect a much larger NK-NKT shared transcriptional 
program than currently appreciated. To assess the extent of transcriptional relatedness 
between iNKT cells and NK cells at a global level, and to compare the NK- iNKT 
relationship and with that of iNKT to T cells, we calculated Euclidian distances between 
subsets of steady-state NK, T and iNKT cells. Euclidian distance, a measure of the similarity 
between the gene expression patterns of pairwise compared subsets, was determined using 
the 15% of gene probes with the highest variability among the subsets analyzed, and is 
displayed as a matrix (Fig. 3). This revealed a strong degree of similarity between mature 
iNKT and NK cell gene expression (Fig. 3, top panel, area i), contrasting greater distances 
observed between all MHC-restricted T cells and NK cells (Fig. 3, top panel, area ii). 
Compared to the iNKT -NK cell distance, iNKT cells exhibited a somewhat closer 
relationship to memory CD8+ T cells and certain memory CD4+ T cell, however, the latter 
were sorted using markers expressed at similar levels by iNKT cells (CD44+ and CD62Llow) 
and likely thus themselves contain a significant percentage of iNKT cells. The average 
Euclidian distance between iNKT and NK cells was only slightly larger than that separating 
iNKT cells from naive CD4+ and CD8+ T cells (Fig. 3, top panel, area iii). These relative 
relationships were maintained when the analysis was performed using all genes and not just 
the 15% most variable (data not shown). To determine whether the NK- iNKT relationship 
is dependent on the shared expression of NKRs, we recalculated the distance matrix after 
removing NKRs and related molecules from the data (see on-line methods). The outcome of 
the analysis remained essentially unchanged (Supplementary Fig. 5). Thus, the 
transcriptional relationship between NK and iNKT cells is not limited to the shared 
expression of NKRs. Together, these data support an unexpectedly substantial 
transcriptional relationship between iNKT and NK cells that is close in magnitude to that 
occurring between iNKT and naive T cells.
Shared and distinct iNKT cells programs
We next sought to identify the specific concordantly-regulated genes among iNKT, NK and 
T cells. For this purpose, we performed one-way analysis of variance (ANOVA) comparing 
the transcriptomes of peripheral steady-state iNKT cells, NK cells and naive and memory 
CD4+ and CD8+ T cells. Genes with low variability over the entire ImmGen dataset were 
excluded from the analysis. 20.2% (1192 genes) of the remaining genes were differentially 
expressed (Bonferroni corrected P value < 0.05) between the three groups. The modulated 
genes were further classified into 6 categories (see on-line methods): genes expressed 
similarly in NK and iNKT cells compared to T cells (A1 or A2, higher or lower than in T 
cells, respectively), genes expressed similarly in iNKT and T cells compared to NK cells (B1 
or B2, higher or lower than in NK cells, respectively), and genes expressed differentially in 
iNKT cells (C1 or C2, higher or lower than T and NK cells, respectively) (Fig. 4a). A 
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number of transcription factors, TCR signaling components, and cytokine or chemokine-
related molecules that are known to be expressed differentially by NK, iNKT, and T cells 
partitioned as expected in the ANOVA categories (Fig. 4b–d). For example, the transcription 
factor PLZF (Zbtb16, Fig. 4b), the chemokine receptor Cxcr6 (Fig. 4c), and a component of 
the high-affinity IL-12 receptor (Il12rb1) (Fig. 4d), all known to be expressed at higher 
levels in iNKT cells than in resting T or NK cells29,30,35,36, partitioned to category C1 
(higher in iNKT cells relative to NK and T cells). The transcription factor T-bet (Tbx21, Fig. 
4b) as well as Il12rb2 (Fig. 4d), known to be upregulated in NK and iNKT cells37, 
partitioned to category A1 (higher in iNKT and NK cells relative to T cells). TCR signaling 
components such as Cd3e, Itk, Plcg1, and Zap70 (Fig. 4c) segregated as anticipated to 
category B1 (higher in iNKT and T compared to NK, Fig. 4c, d). Functional biological 
process enrichment analysis using DAVID software38 of category A1 genes showed a 
statistically significant enrichment for effector functions including NK cell-mediated 
immunity, chemokine or cytokine responses, signal transduction, and cell motility (Table 1). 
Distinct biological processes were also enriched in the group of genes upregulated in iNKT 
cells as compared to NK and MHC-restricted T cells (category C1), and indicated a role for 
these genes in proliferation and survival, likely reflecting the uniquely activated phenotype 
of steady state iNKT cells (Table 2).
We found that a comparable number of genes were expressed similarly in iNKT and NK 
lineages (36.91%, 440 genes, categories A1 and A2) as in iNKT and T cells (43.88%, 523 
genes, categories A2 and B2). In addition, about one-fifth of the differentially expressed 
genes were regulated uniquely in iNKT cells (19.21%, 229 genes, categories C1 and C2) 
(Fig. 4a, Supplementary Table 15). Thus, in addition to expressing a distinctive genetic 
program, iNKT cells share a transcriptional program transcriptional with steady-state NK 
cells that is extensive and similar in magnitude to that shared between iNKT cells and other 
řŚ T cells, consistent with the Euclidian distance analysis.
Thymic induction of NK- iNKT shared programs
To determine at what point during thymic development the transcriptional program shared 
by mature iNKT and NK cells is induced, we analyzed the expression patterns of ANOVA 
category A1 genes over the course of MHC-restricted T and iNKT cell differentiation by 
hierarchical clustering. Although approximately 75% of the shared, upregulated NK- iNKT 
gene program is expressed in early thymic precursors (ETP), these genes are then largely 
shut-down or downregulated by the DP thymocyte stage, and are not reactivated in 
differentiating CD4+ or CD8+ T cells. In contrast, differentiating iNKT cells upregulated 
these same genes, such that stage 3 thymic iNKT cells expressed more than 90% of the 
program (Fig. 5a). Consistent with this observation, the FC distribution of category A1 genes 
calculated by comparing the expression of each gene in developing iNKT cells and their DP 
progenitor showed an increasing shift towards higher FC values with iNKT maturation. All 
three distributions were significantly different from the baseline FC distribution for all 
expressed genes as determined by a Kolmogorov-Smirnov (K-S) test, with P values for 
enrichment of 3.97 × 10−15, 1.28 × 10−19 and 9.14 × 10−48 for stage 1, 2 and 3 iNKT cells 
respectively (Fig. 5b). In contrast, the FC distribution calculated by comparing naïve splenic 
CD4+ or CD8+ T cells to DP was not significantly different between the category A1 geneset 
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and all expressed genes (P = 0.79 and P = 0.65, respectively). Conversely to category A1 
genes, the genes that were significantly downregulated in mature NK and iNKT cells 
compared to T cells (ANOVA category A2) were not as strongly elicited in differentiating 
thymic iNKT cells as in CD4+ and CD8+ T cells (Supplementary Fig. 6). These data extend 
our earlier observation that iNKT cells acquire NKR expression at the end of development, 
and indicate that a large part of the transcriptional program iNKT cells share with NK cells 
is acquired late in thymic maturation.
iNKT cell programs expressed in ͥͦ T cells
We next asked if other lymphocytes with innate features might also express this 
transcriptional program. śŜ T cells can be categorized on the basis of their TCR Vś and VŜ 
chain usage. The subset bearing the Vś2 chain tends to be IL-17 polarized, whereas the 
Vś2− subsets (including Vś1.1+VŜ6.3+ and Vś1.1+VŜ6.3− subsets) predominantly secrete 
TH1 or TH2 cytokines39. Distinct intraepithelial lymphocyte (IEL) CD8řř+ śŜ T cell 
populations posses an effector phenotype similar to that of iNKT cells40,41.
In splenic śŜ T cells negative for the activation marker CD44, NK- iNKT shared genes 
(ANOVA category A1) were expressed at relatively low levels, similar to those observed in 
resting T cells. A subset of these genes was upregulated in splenic CD44+ Vś2+ and Vś2− 
cells. Strikingly, we found that all tissue-resident IEL śŜ T cells expressed a large cluster of 
category A1 genes at levels surpassing those of the reference NK and iNKT populations 
(Fig. 6a). FC distributions comparing the expression of category A1 genes in splenic or IEL 
śŜ T cells and T cells revealed an enrichment of over-expressed genes (P value 4.67 × 10−41 
and 3.90 × 10−34, respectively) (Fig. 6b). IEL śŜ T cells expressed an even smaller 
proportion of ANOVA category A2 genes (downregulated in NK and iNKT compared to T) 
than did iNKT cells, although most of these genes were expressed in splenic śŜ T cells (data 
not shown). Although less prominently than for the shared NK- iNKT cell program 
(category A1) a portion of the genes upregulated in iNKT cells but not T or NK subsets 
(category C1) were also relatively highly expressed in śŜ T cell subsets (Supplementary Fig. 
7a). Together, these data suggest that most of the gene program shared by NK and iNKT 
cells, as well as part of the program differentially upregulated in iNKT cells, is also utilized 
by populations of śŜ T cells at steady state.
NK-iNKT shared program induction in CD8+ T cells
We next investigated the expression of the shared NK- iNKT transcriptional program in 
CD8+ effector T cells, a cell population that shares functional characteristics with NK and 
iNKT cells, including the expression of certain NKRs42. We examined the expression of 
ANOVA categories A1 and A2 in CD8+ T cells from the spleen of ovalbumin (OVA)-
reactive řŚ TCR transgenic (OT-I) mice following infection with Listeria monocytogenes 
expressing OVA. Only a small fraction of ANOVA category A1 genes became upregulated 
in effector CD8+ T cells at 12, 24, and 48 h following Listeria infection. By day 6, however, 
the NK- iNKT shared program was dramatically upregulated, with a FC distribution 
significantly enriched for higher expression, and this genetic program was maintained in 
CD8+ memory T cells as late as day 100 following infection (Fig. 7a, b). In contrast, only a 
limited portion of category C1 genes (differentially expressed by iNKT cells) followed a 
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similar pattern in effector CD8+ T cell populations (Supplementary Fig. 7b). The genes 
downregulated in NK and iNKT cells compared to T cells (ANOVA category A2, which by 
definition are widely expressed in naive OT-I transgenic CD8+ T cells), were partially 
repressed following infection (Supplementary Fig. 8). Similar results were obtained when 
the expression of the NK- iNKT shared transcriptional programs were examined in CD8+ T 
cells from OT-I transgenic mice infected with OVA-expressing vesicular stomatitis virus 
(VSV) (Supplementary Fig. 9). We found that the homologous human genes comprising the 
NK- iNKT shared program (ANOVA category A1) were also expressed at significantly 
higher levels in human peripheral blood effector memory CD8+ T cell populations as 
compared to naive CD8+ T cells43 (Fig. 7c, d). Thus, a large proportion of the genetic 
program shared by NK and iNKT cells is elicited in effector řŚ T cells, but only several 
days following their activation.
Discussion
iNKT cells do not fit the classical paradigm of adaptive T cell immunity. Indeed, innate 
features are at the core their physiological functions3,14. The transcriptional basis for these 
features, however, remains incompletely defined.
The transcriptional programs and regulatory factors we found to be operating during iNKT 
cell maturation were consistent with previous reports, and included Zbtb16 (PLZF), Vdr, 
Tbx21 (Tbet), components of the NF-κB and Ras-MapK pathways, and NKRs4,37,44,45. By 
comparing developing iNKT cells to differentiating MHC-restricted T cells, we define 
transcriptional programs expressed specifically by stage 1 iNKT cells shortly after the DP 
branch point. We thus highlight a large number genes not previously known to affect iNKT 
cell biology but likely modulating iNKT cell thymic maturation specifically.
A number of genes reported to be involved in iNKT cell development were not expressed in 
an iNKT cell specific-manner. For instance, NF-κB and Ras/MapK pathway members such 
as NFkb1, RelB, Ras/MapK and Egr2 were upregulated in both iNKT and non-iNKT 
thymocyte populations4 (data not shown). Other genes known to affect iNKT cells 
ontogeny, Bcl11b46 and the chromatin modifier Med147 for example, exhibited little or no 
transcriptional variation over the course of iNKT cell differentiation. The functional 
regulation of these and other genes not detected in our analyses may thus be controlled at 
post-transcriptional levels.
Mature iNKT cells share several innate functional features with NK cells, developmentally 
distant relatives. We hypothesized that NK and iNKT cells shared a broader transcriptional 
program than is currently appreciated. Our analyses revealed that the transcriptional patterns 
iNKT cells share with NK cells make up nearly as large a part of the iNKT transcriptome as 
those shared with MHC-restricted T cells. Further, we found that the NK- iNKT cell shared 
program was also active in steady-state śŜ T cells subsets similarly poised for rapid, innate-
like responsiveness. The NK- iNKT program can in addition be induced in adaptive řŚ T 
cells, but only days following antigen-specific stimulation. These data suggest that the NK- 
iNKT shared program represents a core effector program operational in lymphocytes of 
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distinct lineages, consistent with the many functional capabilities iNKT, NK and activated 
MHC-restricted T cells have in common.
The factors that regulate expression of this shared effector program remain to be fully 
defined. Nevertheless, our data provides several leads. Acquired largely at the end of thymic 
iNKT cell maturation, the shared program mirrors the cells’  acquisition of NKRs. NKR 
expression is driven by the transcription factor T-bet both in NK and iNKT cells37. Thus, it 
is likely that T-bet, which we found to be among the genes significantly upregulated in both 
NK and iNKT compared to resting T cells, plays an important role in eliciting and 
maintaining at least part of the shared effector lymphocyte program. T-bet-deficient iNKT 
cells express reduced mRNA and protein levels of IFN-ś, granzyme B, Fas ligand, CCR5, 
and CD38, all molecules that are part of the shared program44. IL-15, recently reported to 
act upstream of T-bet in maturing iNKT cells45, is also likely to be involved in iNKT cell 
acquisition of this program. Furthermore, IL-15 and T-bet are important for regulating CD8+ 
effector T cell responses48 as well as for the homeostasis of IEL śŜ T cells49. Thus, IL-15 
and T-bet may play an important role in inducing the expression of the shared effector 
program in several cell types.
We also highlight a number of previously unappreciated transcriptional regulators exhibiting 
similar expression patterns in NK and iNKT cells, and that may help regulate the core 
effector program in innate lymphocytes. For example, the transcription factor Bhlhe40, a 
circadian rhythm regulator50 possessing immune-modulatory functions in CD4+ T cells51,52, 
as well as Smad3, a transcription factor important for tuning TGF-Ś-mediated lymphocyte 
activation, were upregulated in both NK and iNKT cells compared to resting T cells. Also, a 
number of factors were downregulated in NK and iNKT cells. Among these genes were Lef1 
and Tcf7, transcription factors downstream of the Wnt signaling pathway that are important 
for the establishment and maintenance of T cell identity53. Wnt signaling, which is typically 
repressed upon T cell activation54,55. The relatively low expression of Tcf7 and Lef1 in NK 
and iNKT cells during development is consistent with the acquisition their terminally 
differentiated effector phenotype at steady state.
Approximately 20% of the significantly differentially expressed genes between NK, iNKT, 
and T cells exhibited transcriptional patterns specific to iNKT cells. As expected, PLZF 
(Zbtb16) and Gata-3 were among these factors. The genes preferentially upregulated in 
iNKT cells (category C1 genes) were enriched for cellular activation and survival programs. 
For instance, several AP-1 family members (Jun, Junb, Jund, Fos, Fosb and Cebpb) 
normally induced in cells only after activation, were expressed relatively highly in iNKT 
cells. Constitutive expression of AP-1 transcription factors by iNKT cells is consistent with 
their poised effector phenotype.
Together, these data offer a new view of iNKT cells and their relationships to other 
lymphocyte lineages. Using the Immunological Genome consortium database, we have 
uncovered gene expression programs that both link to and differentiate iNKT cells from 
other innate and adaptive lymphocytes. Our data highlight extensive genetic modules that 
are shared with NK cells and other innate-like T cells, and that are also elicited several days 
following activation in adaptive T cells. By defining both distinct and shared transcriptional 
Cohen et al. Page 8
Nat Immunol. Author manuscript; available in PMC 2013 September 06.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
programs in iNKT cells, our data opens avenues for future research and brings into clearer 
focus how lymphocyte populations that differ markedly in their ontogeny can ultimately 
carry out similar effector functions through modular expression of similar transcriptional 
programs.
Online Methods
Mice
6 week old C57BL/6 male mice shipped from Jackson Laboratories one week prior to organ 
harvest were used. Mice were maintained under specific pathogen free conditions. All 
studies were approved by the Animal Care and Use Committee of the Dana-Farber Cancer 
Institute.
Antibodies
Anti-CD19 (MB19-1), anti-B220 (RA3–6B2), anti-Ter119 (TER119), anti-CD11b (M1/70), 
anti-CD11c (N418), anti-Ly6G/Gr1 (A18), anti-CD8ř (53/6.7), anti-TCRŚ (H58–597), anti-
NK1.1 (PK136), anti-CD44 (IM7), anti-CD4 (GK1.5), anti-CD45 (102), anti-CD3ŝ (145–
2C11), anti-Ly49e,f (CM4), anti-NKG2D (CX5), anti-NKG2A (16a11), anti-2B4 
(ebio244F4), and anti-CD16,32 (2.4G2) were from eBioscience. Anti-Ly49a (A1) and anti-
Ly49c,1 (5F6) were from BD biosciences. CD1d-tetramers loaded with PBS-57 (an ř-
galactosylceramide analog) were provided by the NIH tetramer facility.
Cell isolation, microarray analysis and subset nomenclature
All immune cells purification were performed in strict adherence to the ImmGen standard 
Operating Procedure guidelines (available at www.immgen.org). Further details on thymic, 
NK cell, śŜ T cell, and CD8+ T cell populations used for comparison to iNKT cells can be 
found at the ImmGen website. For iNKT cells, thymocytes, splenocytes, liver and lung 
mononuclear cells were isolated from 5–10 mice per sample. Thymocytes were 
disaggregated, blocked with anti-CD16 and CD32 (clone 2.4G2), then stained with 
fluorophore-labeled antibodies for depletion of non- iNKT cell populations, and separated 
with anti-fluorophore magnetic beads (Miltenyi). Spleens were disaggregated, treated with 
ACK lysis buffer (Lonza) to remove red blood cells, and then depleted of non- iNKT cells as 
above. Lungs and livers were harvested after perfusion with cold PBS and mechanically 
homogenized. Lungs were digested for 15 minutes at 37° C in 7 U/ml of Liberase III 
enzyme (Roche) in DMEM, then filtered and washed. Livers were homogenized and liver 
mononuclear cells (LMNC) were isolated by Ficoll density gradient centrifugation. iNKT 
cell-enriched thymocytes, splenocytes, LMNCs and lung cells were stained for cell surface 
markers (see www.immgen.org for complete staining procedure including gating strategy) 
and double sorted directly into Trizol (Invitrogen) at a purity of >99%. By staining 
thymocytes from CD1d-deficient mice that lack iNKT cells, a false positive rate of 2.7 ± 
0.9% was estimated in the case of CD44− NK1.1− (Stage 1) iNKT cells, the rarest thymic 
subset. Contamination was negligible for other iNKT cell populations. Two to four 
replicates were obtained for each sample using a FACSAria, with the exception of the CD4− 
iNKT subset from the lung, for which only a single replicate passed quality control (see 
below). RNA extraction, microarray hybridization (Affymetrix MoGene 1.0 ST array) and 
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data processing were performed at the ImmGen processing center. For further details, please 
see Supplementary Table 16 (subset nomenclature key), the Data Generation and Quality 
Control pipeline documentation, the ImmGen Quality Control Statistics or the ImmGen 
website (www.immgen.org). Non-ImmGen human and mouse datasets were downloaded 
from NCBI Geo datasets43,56. Human homologs of mouse genes were determined using 
NCBI HomoloGene.
Data analysis and visualization
Data from the March 2011 ImmGen release (802 arrays with 22,268 probesets) were used. 
Probesets associated with the same gene symbol were consolidated by selecting the probeset 
with the highest mean expression overall. For heatmaps, data were log2-transformed and a 
relative color scale with row centering (subtraction of the mean) and normalization was 
used. Heatmaps were produced by using the HeatmapViewer module of GenePattern 
(www.broadinstitute.org/cancer/software/genepattern/). When indicated, Pearson correlation 
with pair-wise complete linkage was applied to rows for clustering analysis. Volcano plots 
were produced by using the Multiplot module of GenePattern.
For K-means clustering analysis, genes were pre-filtered for mean expression value ≥ 120 
(cut-off above which genes have a 95% chance of expression) and for FC>2 between any 
two subsets analyzed. Clustering was performed using the ExpressCluster application (Scott 
Davis, Harvard Medical School, Boston MA – application and documentation available at 
http://cbdm.hms.harvard.edu) with K=10.
For Euclidian distance matrices, the 15% most variable genes were identified using the 
PopulationDistances PCA application (Scott Davis), which filters probes based on a 
variation of ANOVA analysis using the geometric standard deviation of populations to 
weight genes that vary in multiple populations. The selected genes were log2-transformed, 
filtered for probes with a mean expression value ≥ 120, and mean centered prior to 
visualization. Activating and inhibitory NKRs, adaptors and signaling partners (Klra1, 
Klra2, Klra3, Klra5, Klra6, Klra8, Klra9, Klra10, Klra17, Klrb1a, Klrb1b, Klrb1c, Klrb1f, 
Klrc1, Klrc2, Klrc3, Klrd1, Klre1, Klri1, Klri2, Klrk1, Klrg2, Ncr1, Cd244, Fcer1g, Tyrobp 
and Hcst) were present in the initial gene list used in the first analysis (Fig. 3, top panel) and 
were manually removed as indicated for the second analysis (Fig. 3, bottom panel). Klra1, 
Klra3, Klra5, Klra6, Klra8, Klra9, Klra10, Klrb1a, Klrb1b, Klrb1c, Klrb1f, Klrc1, Klrc2, 
Klrc3, Klrd1, Klre1, Klri1, Klri2, Klrk1, Ncr1, Cd244, Fcer1g, Tyrobp (but not Klra2, 
Klra17, Klrg2 or Hcst) were present after filtering for 15% most variable gene list and were 
contributed to the first, but not the second Euclidian distance analysis.
For ANOVA, data were log2-transformed, low-variability genes with a standard deviation of 
≤ 0.5 across all ImmGen samples were removed and only genes with expression values ≥ 
120 in 2 or more arrays were considered, leaving 5,900 genes. The ANOVA was performed 
using the Matlab (MathWorks) function “ anova1”  to compare iNKT, NK and T cell 
populations Bonferroni correction was applied to the resulting list of P values, and 1192 
genes passed the ANOVA (p < 0.05 out of 5,900). A secondary test was used to determine 
which of the three populations significantly differed from the other two, as indicated by the 
“ multcompare”  function of Matlab. Based on the results of this analysis, the 1,192 genes 
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were then separated into 14 gene categories. By comparing the average expression levels in 
NK, iNKT, and T cells for each gene, these categories were then sorted into 6 groups of 
genes: genes expressed most similarly by NK and iNKT cells (either A1, up- or A2, 
downregulated compared to T), genes expressed most similarly in T and iNKT (either B1, 
up- or B2, downregulated compared to NK) and genes expressed uniquely in iNKT (either 
C1, up- or C2, downregulated compared to NK and T). Functional geneset enrichment 
analysis was performed using DAVID software (Version 6.7, National Institutes of Health, 
National Institute for Allergy and Infectious Diseases)57. Panther biological processes38 are 
shown in Tables 1 and 2. P values calculated by DAVID represent a modified Fisher Exact 
test. Biological processes with P values less than 0.01 are shown.
For estimation of the significance of enrichment for the FC distributions associated with the 
heatmaps in Figs. 5–7, Kolmogorov-Smirnov P values were calculated with JMP (SAS 
Institute) comparing the selected geneset to all genes meeting the criteria for expression 
(>120) in the samples tested.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
iNKT cells upregulate NKRs at the end of thymic differentiation. (a) Flow cytometric 
identification of thymic iNKT cells. (b) Number of genes differentially expressed during 
iNKT cell developmental transitions. (c) Genes differentially expressed between DP 
thymocytes and stage 1 (top), stage 1 and stage 2 (middle), and stage 2 and stage 3 iNKT 
cells (bottom). Genes upregulated are highlighted in red or blue, respectively. See 
Supplementary Tables 1–6 for complete lists. (d) Genes differentially expressed in stage 1 
iNKT cells versus DP thymocytes. Colored highlights indicate genes differentially regulated 
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in iNKT but not in CD4+8int compared to DP thymocytes. See Supplementary Tables 7 and 
8 for complete lists. For b-d, only genes with expression above the detection level one or 
more subsets and a coefficient of variation (CV) < 0.5 in all subsets were considered. The 
differential expression threshold used was FC > 2. (e) Expression of NKRs in differentiating 
thymocytes (see Supplementary Table 16 for key to subset nomenclature). Values were 
log2-transformed, row centered and locally color scaled. (f) NKR surface expression as 
determined by flow cytometry. Bars, mean percentage-positive ± s.e.m., n=3 mice. Data is 
representative of at least two independent experiments. (g) Expression of an NKR-
containing gene cluster derived from a Euclidian distance-based K-means clustering analysis 
(mean correlation, 0.958). Genes were pre-filtered for expression and for FC > 2 between 
any 2 subsets, and data was log2-transformed. Klra3, 5, 6, 9, 10, Klrb1b, c, f, Klrc1, 2, 3, 
Klrd1, Klri2 and Klrk1 are labeled in red.
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Fig. 2. 
Expression of NKRs in peripheral CD4+ and CD4− iNKT cells. (a) Top, differential gene 
expression between CD4+ and CD4iNKT cells from the spleen; bottom, differential gene 
expression between CD4+ and CD4− iNKT cells from the liver. Genes up- or downregulated 
with FC > 2 in CD4− compared to CD4+ subsets are highlighted in red or blue, respectively. 
Only genes with expression values above the detection level in at least one subset and a CV 
< 0.5 in all subsets are displayed. (b) Flow cytometric quantification of NKRs on spleen and 
liver CD4+ and CD4− iNKT cells. Bars represent mean percentage-positive for surface 
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expression ± s.e.m., n=3 mice. Data is representative of at least two independent 
experiments. (c) NKR expression in peripheral MHC-restricted T and iNKT cell subsets. 
Values were log2-transformed, gene row centered and local color scaling was used. See 
Supplementary Table 16 for key to subset nomenclature.
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Fig. 3. 
The global transcriptional relationship between NK and iNKT cells is similar in magnitude 
to the relationship between T and iNKT cells. Euclidian distance matrix calculated using the 
15% most variable probes. Only genes with mean expression values above 120 were 
included in these analyses, and data was log2 transformed and mean centered. Numbers 
represent average Euclidian distances between intersecting subsets. Note that the matrix is 
symmetrical along the indicated diagonal. Areas of interest are marked with lowercase 
Roman numerals.
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Fig. 4. 
Characterization of shared and differential gene expression among iNKT, NK, and T cells. 
One-way ANOVA was performed to compare gene expression in iNKT, NK, and T cell 
populations. Differentially expressed genes were separated into six categories depending on 
common patterns in 2 of the 3 subsets. Genes up- (A1) or down- (A2) regulated in NK and 
iNKT compared to T cells; genes up- (B1) or down- (B2) regulated in iNKT and T compared 
to NK cells; genes up- (C1) or down- (C2) regulated in iNKT compared to T or NK cells. (a) 
Left, heatmap of genes expressed differentially in iNKT, NK, and T cells for the indicated 
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cell subsets, separated according to category; right, proportion of differentially expressed 
genes in each category. (b-d) Expression of ANOVA category genes in relevant manually 
selected functional gene groups (see methods). Genes reported in the literature to be highly 
expressed in each category shown in underlined bold. In all heatmaps, rows are mean-
centered and normalized, and local scaling is used. See Supplementary Table 16 for key to 
subset nomenclature.
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Fig. 5. 
Transcriptional programs shared between NK and iNKT cells are acquired during thymic 
iNKT cell maturation. (a) Top, relative expression of genes significantly upregulated in 
peripheral NK and iNKT cells (ANOVA category A1) over the course of thymic T and 
iNKT cell maturation. Genes were ordered by hierarchical clustering using Pearson 
correlation. Rows are mean-centered and normalized, and local scaling is used. Bottom, 
percentages of genes exceeding the threshold for expression over the course of thymic 
maturation. T cell populations are represented in the same order as in the heatmaps. (b) FC 
distribution of category A1 genes in stage 1, 2 and 3 iNKT cells compared to DP thymocytes 
with individual genes displayed in rank-order along the y-axis. P values represent 
Cohen et al. Page 22
Nat Immunol. Author manuscript; available in PMC 2013 September 06.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
significance of K-S test comparing the FC distribution of the ANOVA category A1 geneset 
to that of all expressed genes. See Supplementary Table 16 for key to subset nomenclature.
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Fig. 6. 
Activated splenic śŜ T cells and IEL śŜ T cells express NK- iNKT shared gene programs. 
(a) Relative expression of genes significantly upregulated in peripheral NK and iNKT 
compared to T cells (ANOVA category A1) in the splenic and IEL śŜ T cell subsets 
indicated. Averaged values for the ANOVA subsets (iNKT, NKT and T) are displayed for 
comparison. Genes are ordered by hierarchical clustering using Pearson correlation. Rows 
are mean-centered, normalized and local color scaling is used. (b) ANOVA category A1 
gene FC distributions for averaged splenic and IEL śŜ T cell subsets compared to the 
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averaged T cell subset displayed with individual genes displayed in rank-order along the y-
axis. P values represent significance of K-S test comparing the distribution of the ANOVA 
category A1 geneset to that of all expressed genes. See Supplementary Table 16 for key to 
subset nomenclature.
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Fig. 7. 
NK-iNKT shared gene programs are induced in activated CD8+ T cells. (a) Relative 
expression of genes significantly upregulated in peripheral NK and iNKT cells (ANOVA 
category A1) in antigen-specific CD8+ T cells over the course of Listeria-OVA infection. 
See Supplementary Table 16 for key to subset nomenclature. (b) ANOVA category A1 gene 
FC distributions for activated CD8+ T cells compared to the naive control with individual 
genes displayed in rank-order along the y-axis. (c) Relative expression of the human gene 
homologs from ANOVA category A1 in human peripheral blood CD8+ T cell subsets from 
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different donors43. (d) FC distributions for human memory CD8+ T cells compared to the 
naive control, using human homologs of the ANOVA category A1 geneset. For all 
heatmaps, genes were ordered by hierarchical clustering using Pearson correlation. Rows are 
mean-centered and normalized, and relative scaling is used. For FC distribution plots, P 
values represent significance of K-S test comparing the distribution of the ANOVA category 
A1 geneset to that of all expressed genes. Nve., naïve; Ctr. Mem., central memory; Eff. 
Mem., effector memory.
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Table 1
Functional pathway enrichment for ANOVA category A1 genes
Biological process Genes present Fold-
enrichment
P value
BP00157:
Natural killer cell
mediated immunity
Klrc2, Klrc3, Ifng, Klrb1f,
Klrk1, Klrb1c, Klrc1 13.70 1.11 × 10
−5
BP00255:
Cytokine/chemokine
mediated immunity
Ccrl2, Ccr5, Ifng, Ccr2, Xcl1,
Ccl5 7.31 1.33 × 10
−3
BP00107:
Cytokine and
chemokine mediated
signaling pathway
Ccrl2, Il12rb2, Ccr5, Ifng,
Ccr2, Inpp5d, Xcl1, Ccl5 4.31 2.49 × 10
−3
BP00287:
Cell motility
Ccrl2, Coro2a, Dok2, Ccr5,
Ccr2, Anxa1, Abi2, Dock5,
Diap1
3.68 2.98 × 10−3
BP00148:
Immunity and defense
F2rl2, Klrc2, Klrc3, Fgr,
Cysltr2, Adora2a, Tbx21,
Klrk1, Ccl5, Ccrl2, Cd97,
Il12rb2, Ifng, Irak2, Klf6,
Il18rap, Lgals3, Gzmb,
Sh2d2a, Ccr5, Ccr2, Klrb1f,
Xcl1, Klrb1c, Klrc1, Sema4a
2.11 3.57 × 10−4
BP00102:
Signal transduction
F2rl2, Klrc2, S100a6, Gna15,
Klrc3, Fgr, Adora2a, Cysltr2,
Gpr65, Klrk1, Abi2, Itgb2,
Ccl5, Prkx, Il12rb2, Cd97,
Ccrl2, Coro2a, Zfp36l2,
Plcb3, Ifng, Rhob, Fgl2,
Rhoc, Fasl, Inpp5d, Ptprj,
Irak2, Abr, Rxra, Anxa1,
Ntng2, Smad3, Gem, Dock5,
Arhgap26, Dusp5, Dok2,
Dusp2, Ccr5, Rgs2, Rgs3,
Ccr2, Chn2, Xcl1, Sema4a,
Klrc1
1.55 6.50 × 10−4
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Table 2
Functional pathway enrichment for ANOVA category C1 genes
Biological process Genes present Fold-
enrichment
P value
BP00116:
JNK cascade
Vav3, Dusp1, Jun,
Jund, Junb, Cxcl10 14.49 5.45 × 10
−5
BP00265:
Oncogene
Fos, Vav3, Lmo4, Jun,
Jund, Etv5, Junb 10.35 5.53 × 10
−5
BP00263:
Inhibition of apoptosis
Il4, bcl2a1d, bcl2a1c,
cebpb, socs2, bcl2a1b,
bcl2a1a
8.11 2.13 × 10−4
BP00179:
Apoptosis
Il4, bcl2a1d, bcl2a1c,
cebpb, socs2, bcl2a1b,
bcl2a1a, tnfsf14, nfkbia,
gadd45b, emp1
3.25 1.88 × 10−3
BP00281:
Oncogenesis
Fos, vav3, lmo4, jun,
jund, fam129a, etv5,
junb, emp1
3.13 7.59 × 10−3
BP00111:
Intracellular signaling
cascade
Il4, cap2, vav3, socs2,
rab4a, nfkbia, junb,
cxcl10, plk3, dusp1, jun,
jund, gadd45b, tbkbp1,
dusp6, rab27a
2.78 5.12 × 10−4
BP00040:
mRNA transcription
Dtx4, cebpb, lmo4,
nfkbia, fosb, arntl,
zbtb16, rora, junb, hic1,
fos, npas2, nr1d1,
gata3, jun, jund,
dennd4c, thoc4, gfi1,
rbpj, etv5, klf4
1.76 9.97 × 10−3
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